• Markets
    • icon
  • Companies
AYA · ASX

Artrya Limited (ASX:AYA)

AU$0.31

 0.06 (24.0%)
ASX:Live
26/07/2024 03:14:29 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AYA Overview

AYA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About AYA

Website

N/A

Telephone

61.8.6478.7816

Address

1257 Hay Street West Perth, Western Australia (WA) 6005

Description

Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). It uses artificial intelligence (AI) to improve the detection and management of coronary artery disease. The company was founded by John Windsor Barrington and John Konstantopoulos on January 24, 2018 and is headquartered in West Perth, Australia.

AYA Price Chart

Key Stats

Market Cap

AU$18.10M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.16 - 0.42

Trade Value (12mth)

AU$3,044.00

1 week

4.17%

1 month

19.05%

YTD

0%

1 year

8.7%

All time high

1.75

Key Fundamentals

EPS 3 yr Growth

721.400%

EBITDA Margin

N/A

Operating Cashflow

-$11m

Free Cash Flow Return

-29.30%

ROIC

-30.40%

Interest Coverage

-204.70

Quick Ratio

14.90

Other Data

Shares on Issue (Fully Dilluted)

79m

HALO Sector

Technology

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AYA Announcements

Latest Announcements

Date Announcements

27 June 24

Notification regarding unquoted securities - AYA

×

Notification regarding unquoted securities - AYA

12 June 24

Notification regarding unquoted securities - AYA

×

Notification regarding unquoted securities - AYA

11 June 24

Five year Strategic Agreement with Cone Health

×

Five year Strategic Agreement with Cone Health

11 June 24

Proposed issue of securities - AYA

×

Proposed issue of securities - AYA

07 June 24

Artrya Lodges Q-Submission

×

Artrya Lodges Q-Submission

24 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

02 April 24

Artrya Commences Commercial Operations in Australia

×

Artrya Commences Commercial Operations in Australia

02 April 24

Issue of Shares on Exercise of Options and Cleansing Notice

×

Issue of Shares on Exercise of Options and Cleansing Notice

02 April 24

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

26 March 24

Notification of cessation of securities - AYA

×

Notification of cessation of securities - AYA

15 March 24

Change of Share Registry Details

×

Change of Share Registry Details

12 March 24

Strategic Commercial Agreement with Tanner Health System

×

Strategic Commercial Agreement with Tanner Health System

12 March 24

Proposed issue of securities - AYA

×

Proposed issue of securities - AYA

12 March 24

Notification regarding unquoted securities - AYA

×

Notification regarding unquoted securities - AYA

29 February 24

Appendix 4D & Interim Financial Report

×

Appendix 4D & Interim Financial Report

29 February 24

AYA - Half Year Results Announcement

×

AYA - Half Year Results Announcement

31 January 24

Quarterly Activities and Cashflow Report

×

Quarterly Activities and Cashflow Report

19 December 23

Change in Director's Interest Notice - K HIll

×

Change in Director's Interest Notice - K HIll

19 December 23

Change in Director's Interest Notice - J Sokolov

×

Change in Director's Interest Notice - J Sokolov

30 November 23

Chair and CEO Annual General Meeting Address

×

Chair and CEO Annual General Meeting Address

30 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

29 November 23

Annual General Meeting - Link

×

Annual General Meeting - Link

27 November 23

Ceasing to be a Substantial Holder - Artrya Limited

×

Ceasing to be a Substantial Holder - Artrya Limited

27 November 23

Application for quotation of securities - AYA

×

Application for quotation of securities - AYA

22 November 23

Notification regarding unquoted securities - AYA

×

Notification regarding unquoted securities - AYA

AYA Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.05 -0.26 -0.14 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.05 -0.26 -0.14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -201.7 -396.6 45.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.04 -0.14 -0.13 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.17 -0.14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -107.7 -299.6 4.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -26.7 -64.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.18 0.52 0.39 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.17 0.47 0.30 Lock Lock Lock
     Growth % Lock Lock Lock Lock 437.0 175.6 -37.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 78 66 78 Lock Lock Lock
Basic m Lock Lock Lock Lock 78 66 78 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 17 12 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -233.6 -424.5 -173.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 -17 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -140.9 -294.7 28.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -4 -17 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -141.5 -295.9 26.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -4 -17 -11 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -17 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -201.3 -320.5 35.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -1 -10 -11 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 6 6 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -27 16 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 14 39 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -2 -11 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 3.5 -626.5 3.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 13 36 20 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 15 44 33 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -13 -34 -19 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 3 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 14 41 31 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 14 42 31 Lock Lock Lock
     Growth % Lock Lock Lock Lock 458.0 200.3 -24.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -27.1 -39.1 -33.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -29.3 -42.2 -36.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -51.5 -60.0 -33.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -49.7 -61.6 -30.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -18.1 -34.5 -29.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -157.1 -789.7 -204.7 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.1 2.1 1.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -93.0 -84.1 -62.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 12.5 18.4 14.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 12.5 18.4 14.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 90.1 93.9 86.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -128.5 -465.6 -673.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -27.1 -39.1 -33.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -29.3 -42.2 -36.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A -42.2 -36.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 2,237.9 814.6 229.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -2,237.9 -814.6 -229.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AYA Shortsell

Frequently Asked Questions

The current share price of Artrya Limited (AYA:ASX) is AU$0.31.
The 52-week high share price for Artrya Limited (AYA:ASX) is AU$0.42.
The 52-week low share price for Artrya Limited (AYA:ASX)? is AU$0.16.
Artrya Limited (AYA:ASX) does not pay a dividend.
Artrya Limited (AYA:ASX) does not pay a dividend.
Artrya Limited (AYA:ASX) has a franking level of 0.0%.
Artrya Limited (AYA:ASX) is classified in the Technology.
The current P/E ratio for Artrya Limited (AYA:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.